NCT00500357View on ClinicalTrials.gov

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Vaccines, Pneumococcal Conjugate Vaccine

Interventions

BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

1 dose 13vPnC

Trial Locations (16)

1827

Lenasia

1911

Vanderbijlpark

4126

eManzimtoti

4180

Scottburgh South

7490

Bishop Lavis

7500

Parow

7646

Paarl

7941

Cape Town

7945

Cape Town

9317

Bloemfontein

9585

Parys

0250

Brits

0002

Pretoria

0082

Pretoria

0083

Pretoria

0183

Pretoria

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00500357 - Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects | Biotech Hunter | Biotech Hunter